ACR Convergence Replay Webinar: 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis
About the Event
Date:May 14, 2025 | 7:00–8:30 PM ET
Location:Virtual
Credit:No Credit
On Demand:To Be Announced
The ACR Convergence Replay 2024 webinar includes a recorded session from ACR Convergence followed by a live Q&A with the presenters to answer your questions and provide further insights.
This session will describe the new lupus nephritis (LN) guideline, which was based on a standardized protocol that prioritized relevant clinical questions about LN treatments and a systematic literature review. The session will review the methods used and recommendations made and will demonstrate how to use the new guideline in a clinical setting using a case-based format, with particular emphasis on specific, challenging scenarios.
Target Audience
Rheumatologists, physicians, healthcare providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss with a colleague how the new lupus nephritis guidelines were developed
- Explain to a colleague or patient the newest diagnostic recommendations for lupus nephritis
- Explain to a colleague or patient the newest recommendations for the management of lupus nephritis
ACR Convergence 2024 All Access Attendees:
Register for Free
If you attended ACR Convergence 2024 (All Access pass) and missed a session or didn’t ask the presenter a question, don’t worry – we've got you covered. You can register for the ACR Convergence 2024 Replay event for free.
Spots are limited, so please complete the form below to request access. We will send an exclusive link to register two weeks before the event.
Note: On-demand access available for registered attendees. On-demand access will also be available for purchase to non-registrants within 30 days of the live program.
Program Schedule & Syllabi
Registered attendees can access the syllabi during the meeting and until 11:59 PM ET on December 31, 2025. To access syllabi, login and go to My Learning.
Registration Fees
Registration is open until May 13 at 5:00 PM ET.
ACR Member: $99
ARP Member: $79
Potential ACR/ARP Member: $149
Registration Guidelines
Full payment is due at the time of registration. Registration closes May 13 at 5:00 PM ET.
Cancellations and Refund Requests
- Cancellations and refund requests must be received in writing by May 7, at education@rheumatology.org. Refunds will not be provided for cancellations received after the cancellation deadline.
- A cancellation fee of $50 will be deducted.
- Refund requests received will be processed within 2–3 weeks of receipt.
- No-shows will not receive a refund.
- Cancelled registrations are nontransferable.
Corporate Support
The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.
See current supporters, guidelines, and benefits of supporting the ACR.
This activity is not eligible for CME/MOC.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
*All of the relevant financial relationships listed for these individuals have been mitigated.
ACR Convergence Replay Webinar: 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis Disclosures (coming soon)